Mapping geographic areas of high and low drug adherence in patients prescribed continuing treatment for acute coronary syndrome after discharge

Pharmacotherapy

Volumn 31, Issue 10, 2011, Pages 927-933

  Hoang, Cuong ^a   Kolenic, Giselle ^a   Kline Rogers, Eva ^b   Eagle, Kim A ^b,c   Erickson, Steven R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

ACS; Acute coronary syndrome; Cardiovascular disease; Geographic information system; GIS; Medication adherence; Medication persistence

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC INFORMATION SYSTEM; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PRESCRIPTION; TREATMENT DURATION; UNIVERSITY HOSPITAL; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; DRUG UTILIZATION REVIEW; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; GEOGRAPHIC INFORMATION SYSTEMS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEDICATION ADHERENCE; RETROSPECTIVE STUDIES;

EID: 80053320744     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.10.927     Document Type: Article

References (34)

1. Antman E, Anbe D, Kushner F, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 2004;110:e82-293.
2. Fox K, Steg P, Eagle K, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007;297:1892-900.
3. Jackevicius C, Mamdani M, Tu J. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462-7. (Pubitemid 34787477)
4. Cline CMJ, Bjork-Linne AK, Israelsson BYA, Willenheimer RB, Erhardt LR. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999;1:145-9. (Pubitemid 30186705)
5. Dunbar-Jacob J, Bohachick P, Mortimer M, Sereika SM, Foley SM. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs 2003;18:209-18.
6. Gallagher E, Viscoli C, Horwitz R. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993;270:742-4. (Pubitemid 23226634)
7. Ho M, Peterson E, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008;299:532-9. (Pubitemid 351222546)
8. Sud A, Kline-Rogers E, Eagle K, et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother 2005;39:1792-7. (Pubitemid 41527689)
9. Kennedy J, Coyne J, Sclar D. Drug affordability and prescription noncompliance in the United States: 1997-2002. Clin Ther 2004;26:607-14.
10. Rice T, Lavarreda SA, Ponce NA, Brown RB. The impact of private and public health insurance on medication use for adults with chronic diseases. Med Care Res Rev 2005;62:231-49. (Pubitemid 40397255)
11. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998;20:764-71. (Pubitemid 28421497)
12. Dunbar-Jacob J, Mortimer-Stephens M. Treatment adherence in chronic disease. J Clin Epid 2001;54:S57-60.
13. Burke L, Dunbar-Jacob J, Hill M. Compliance with cardiovascular disease prevention strategies: a review of the research. Ann Behav Med 1997;19:239-63. (Pubitemid 28196285)
14. Jackevicius C, Li P, Tu J. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008;117:1028-36.
15. Vermeire E, Hearnshaw H, Van Royen P. Patient adherence to treatment: three decades of research - a comprehensive review. J Clin Pharm Ther 2001;26:331-42. (Pubitemid 32989555)
16. Morris LS, Schulz R. Medication compliance: the patient's perspective. Clin Ther 1993;15:593-606. (Pubitemid 23194636)
17. Diez Roux AV. Residential environments and cardiovascular risk. J Urban Health 2003;80:569-89. (Pubitemid 38146222)
18. Diez Roux AV. Persistent social patterning of cardiovascular risk. Circulation 2005;111:3020-1. (Pubitemid 40847776)
19. Tonne C, Schwartz J, Mittleman M. Long-term survival after acute myocardial infarction is lower in more deprived neighborhoods. Circulation 2005;111:3063-70. (Pubitemid 40847783)
20. Isaacs SL, Schroeder SA. Class-the ignored determinant of the nation's health. N Engl J Med 2004;351:1137-42. (Pubitemid 39167519)
21. Morland K, Diez Roux AV, Wing S. Supermarkets, other food stores, and obesity: the arthrosclerosis risk in communities study. Am J Prev Med 2006;30:333-9. (Pubitemid 43357923)
22. Diez Roux AV, Evenson KR, McGinn AP, et al. Availability of recreational resources and physical activity in adults. Am J Public Health 2007;97:493-9. (Pubitemid 47280201)
23. Egede LE, Gebregziabher M, Hunt KJ, et al. Regional, geographic, and ethnic differences in medication adherence among adults with type 2 diabetes. Ann Pharmacother 2011;45:169-78.
24. King WK, Minor P, Kitchen CR, et al. Racial, gender and geographic disparities of antiretroviral treatment among U.S. Medicaid enrollees in 1998. J Epidemiol Community Health 2008;62:798-803.
25. Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996-2002. Med Care 2006;44:1005-10.
26. Meliker JR, Sloan CD. Spatio-temporal epidemiology: principles and opportunities [online exclusive article]. Spat Spattemporal Epidemiol 2011;2:1-9. Available from http://dx.doi.org/10.1016/j.sste.2010.10.001.
27. Peled R, Reuveni H, Pliskin JS, Beneson I, Hatna E, Tal A. Defining localities of inadequate treatment for childhood asthma: a GIS approach [online exclusive article]. Int J Health Geogr 2006;5:3. Available from http://www.ij-healthgeographics.com/content/5/1/3.
28. Czarnecki KD, Goranson C, Ellis JA, Vichinsky LE, Coady MH, Perl SB. Using geographic information system analyses to monitor large-scale distribution of nicotine replacement therapy in New York City. Prev Med 2010;50:288-96.
29. Brownstein JS, Green TC, Cassidy TA, Butler SF. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol Drug Saf 2010;19:627-37.
30. Eagle KA, Kline-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 2004;117:73-81. (Pubitemid 38953725)
31. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002;106:388-91.
32. O'Campo P. Invited commentary: advancing theory and methods for multilevel models of residential neighborhoods and health. Am J Epidemiol 2003;157:9-13. (Pubitemid 36043731)
33. Diez-Roux AV. Investigating neighborhood and area effects on health. Am J Pub Health 2001;91:1783-9.
34. Becker M, Maiman L. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975;3:10-24.